CGEN (cgen.com) Long-Term Debt

The current Compugen Ltd. (CGEN) share price chart on the GURU.Markets platform highlights the success of digital target discovery for therapy, enabling the company to secure premium payments from pharma behemoths, with the indicator standing at 0.00. Financial stability is supported by the transfer of rights to early-stage developments, which ensures a steady profit inflow. Human capital potential is based on the loyalty of leading scientists, whose motivation is reinforced through stock option programs.

The stability of long-term liabilities determines the issuer's financial resilience and its ability to service capital. This metric captures the total liabilities with a maturity of more than one year, reflecting the funding structure's dependence on market interest rates. By analyzing a firm's long-term borrowed funds, an investor assesses the debt load risk. For Compugen Ltd. (CGEN), this is critical, as the absence of a proprietary product makes the company dependent on external financing and licensing payments.